ConductScience.org, home

Paper337487

Posttranslational covalent modification of proteins.

Uy R and 1 other. Science, 1977. Cited by 285 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Posttranslational covalent modification of proteins. Papers, record 337487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/337487

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Posttranslational covalent modification of proteins.
PubMed
Journal
Science
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
285
iCite
Relative citation ratio, by iCite
6.15
iCite
Revised in PubMed
2019-06-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uy RR
2Wold FF

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Protein PrecursorsMajor topic
ProteinsMajor topic
Amino Acid Sequence
Amino Acids
Cytosol
Enzymes
Hydrolysis
Protein Biosynthesis
RNA, Transfer
Substrate Specificity

Source PubMed

Cited by82

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 285 citations.

PMIDTitleJournalYearIn PapersSource
42,249,270Hydrogen sulfide-mediated protein s-persulfidation: a regulatory mechanism in cardiovascular homeostasis.Mol Med2026https://conductscience.org/library/papers/42249270PubMed
42,183,207Succinylation in cancer immunotherapy: mechanisms, biomarkers, and therapeutic implications.Front Immunol2026https://conductscience.org/library/papers/42183207PubMed
41,373,704Emerging Roles of Post-Translational Modifications in Metabolic Homeostasis and Type 2 Diabetes.Int J Mol Sci2025https://conductscience.org/library/papers/41373704PubMed
41,350,808Probing tau citrullination in Alzheimer's disease brains and mouse models of tauopathy.Acta Neuropathol2025https://conductscience.org/library/papers/41350808PubMed
41,140,820XXYLT1 inhibits NOTCH1 activation in Jurkat cells while promoting cell proliferation.Nagoya J Med Sci2025https://conductscience.org/library/papers/41140820PubMed
41,090,352Citrullination in tumor immunity and therapy.J Clin Invest2025https://conductscience.org/library/papers/41090352PubMed
40,720,394Lactylation and viral infections: A novel link between metabolic reprogramming and immune regulation.PLoS Pathog2025https://conductscience.org/library/papers/40720394PubMed
40,267,484Implications of Protein Posttranslational Modifications in Sepsis-Induced Acute Lung Injury and Acute Respiratory Distress Syndrome.Shock2025https://conductscience.org/library/papers/40267484PubMed
38,540,730Post-Translational Modifications and Diabetes.Biomolecules2024https://conductscience.org/library/papers/38540730PubMed
38,489,266PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages.Cell Rep2024https://conductscience.org/library/papers/38489266PubMed
38,335,294The protein carboxymethyltransferase-dependent aspartate salvage pathway plays a crucial role in the intricate metabolic network of Escherichia coli.Sci Adv2024https://conductscience.org/library/papers/38335294PubMed
38,137,883Xeno Amino Acids: A Look into Biochemistry as We Do Not Know It.Life (Basel)2023https://conductscience.org/library/papers/38137883PubMed
37,920,756Electrochemical synthesis and antimicrobial evaluation of some N-phenyl α-amino acids.RSC Adv2023https://conductscience.org/library/papers/37920756PubMed
36,555,449
Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis.
Int J Mol Sci2022https://conductscience.org/library/papers/36555449PubMed
36,539,894NAA60 (HAT4): the newly discovered bi-functional Golgi member of the acetyltransferase family.Clin Epigenetics2022https://conductscience.org/library/papers/36539894PubMed
36,389,721Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes.Front Immunol2022https://conductscience.org/library/papers/36389721PubMed
36,029,409Post-translational Modifications in Brain Diseases: A Future for Biomarkers.Adv Exp Med Biol2022https://conductscience.org/library/papers/36029409PubMed
34,827,739Emergence and Enhancement of Ultrasensitivity through Posttranslational Modulation of Protein Stability.Biomolecules2021https://conductscience.org/library/papers/34827739PubMed
34,140,951Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.Front Immunol2021https://conductscience.org/library/papers/34140951PubMed
33,798,408Discovering the landscape of protein modifications.Mol Cell2021https://conductscience.org/library/papers/33798408PubMed

See all 82 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/337487

GET https://conductscience.org/api/papers/v1/337487/cited_by?page=2